Comment on: Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis

Br J Cancer. 2020 Oct;123(9):1464-1465. doi: 10.1038/s41416-020-1003-7. Epub 2020 Jul 28.

Pei Pei Che^{1

2}, Alessandro Gregori², Godefridus J Peters^{2

3}, Max Dahele¹, Peter Sminia¹, Elisa Giovannetti^{4

5}

¹ Department of Radiation Oncology, Amsterdam University Medical Centers, VU University, Cancer Center Amsterdam, Amsterdam, The Netherlands.
² Department of Medical Oncology, Amsterdam University Medical Centers, VU University, Cancer Center Amsterdam, Amsterdam, The Netherlands.
³ Department of Biochemistry, Medical University of Gdansk, Gdańsk, Poland.
⁴ Department of Medical Oncology, Amsterdam University Medical Centers, VU University, Cancer Center Amsterdam, Amsterdam, The Netherlands. elisa.giovannetti@gmail.com.
⁵ Cancer Pharmacology Lab, AIRC Start-Up Unit, Fondazione Pisana per la Scienza, Pisa, Italy. elisa.giovannetti@gmail.com.

No abstract available

Publication types